Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration

Author： Roemer-Becuwe C.   Vigano A.   Romano F.   Neumann C.   Hanson J.   Quan H.K.   Walker P.  

Publisher： Elsevier

ISSN： 0885-3924

Source： Journal of Pain and Symptom Management, Vol.26, Iss.3, 2003-09, pp. : 843-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency

By Hagan John   Fasano Mary   Spector Sheldon   Wasserman Richard   Melamed Isaac   Rojavin Mikhail   Zenker Othmar   Orange Jordan  

Journal of Clinical Immunology, Vol. 30, Iss. 5, 2010-09 ,pp. : 734-745

Springer Publishing Company

Access to resources Recommend Favorite

Safety and Efficacy of Self-Administered Subcutaneous Immunoglobulin in Patients with Primary Immunodeficiency Diseases

By Ochs Hans   Gupta Sudhir   Kiessling Peter   Nicolay Uwe   Berger Melvin  

Journal of Clinical Immunology, Vol. 26, Iss. 3, 2006-05 ,pp. : 265-273

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases

By Kanegane Hirokazu   Imai Kohsuke   Yamada Masafumi   Takada Hidetoshi   Ariga Tadashi   Bexon Martin   Rojavin Mikhail   Hu Wilson   Kobayashi Midori   Lawo John-Philip   Nonoyama Shigeaki   Hara Toshiro   Miyawaki Toshio  

Journal of Clinical Immunology, Vol. 34, Iss. 2, 2014-02 ,pp. : 204-211

Springer Publishing Company

Access to resources Recommend Favorite

Bioavailability of IgG Administered by the Subcutaneous Route

By Berger Melvin   Jolles Stephen   Orange Jordan   Sleasman John  

Journal of Clinical Immunology, Vol. 33, Iss. 5, 2013-07 ,pp. : 984-990

Springer Publishing Company

Access to resources Recommend Favorite

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

By Nussenblatt R.B.   Thompson D.J.S.   Li Z.   Peterson J.S.   Robinson R.R.   Shames R.S.   Nagarajan S.   Tang M.T.   Mailman M.   Velez G.   Roy C.   Levy-Clarke G.A.   Suhler E.B.   Djalilian A.   Sen H.N.   Al-Khatib S.   Ursea R.   Srivastava S.   Bamji A.   Mellow S.   Sran P.   Waldmann T.A.   Buggage R.R.  

Journal of Autoimmunity, Vol. 21, Iss. 3, 2003-11 ,pp. : 283-293

Elsevier

Access to resources Recommend Favorite